Reader response: Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss
暂无分享,去创建一个
[1] P. Lockhart,et al. Familial early onset Parkinson's disease caused by a homozygous frameshift variant in PARK7: Clinical features and literature update. , 2019, Parkinsonism & related disorders.
[2] D. Goldstein,et al. Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss , 2019, Neurology.
[3] Hidetaka Mitsumura,et al. Transcranial color-coded sonography findings of patients with reversible cerebral vasoconstriction syndromes , 2019, Journal of Clinical Neuroscience.
[4] A. Singhal,et al. RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome , 2019, Neurology.
[5] N. Hattori,et al. MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson’s Disease , 2018, Journal of Parkinson's disease.
[6] Yen-Feng Wang,et al. Vascular wall imaging in reversible cerebral vasoconstriction syndrome – a 3-T contrast-enhanced MRI study , 2018, The Journal of Headache and Pain.
[7] P. Petramfar,et al. A Clinical and Molecular Genetic Study of 50 Families with Autosomal Recessive Parkinsonism Revealed Known and Novel Gene Mutations , 2017, Molecular Neurobiology.
[8] E. Bertini,et al. DJ‐1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7 , 2017, Clinical genetics.
[9] M. Frosch,et al. Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison , 2016, Annals of neurology.